Murine gammaherpesvirus 68: A model for the study of Epstein-Barr virus infections and related diseases

Comparative Medicine

Volumn 57, Issue 1, 2007, Pages 44-50

  Olivadoti, Melissa ^a   Toth, Linda A ^c   Weinberg, Jason ^a   Opp, Mark R ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODEL; EPSTEIN BARR VIRUS; EXPERIMENTAL MOUSE; HERPES VIRUS; HUMAN; IMMUNOPATHOGENESIS; INFECTIOUS MONONUCLEOSIS; INTERSTITIAL LUNG DISEASE; LATENT VIRUS INFECTION; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; REVIEW; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; EPSTEIN-BARR VIRUS INFECTIONS; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; HUMANS; MICE; SPECIES SPECIFICITY;

EID: 33847274228     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Ablashi DV. 1994. Summary: viral studies of chronic fatigue syndrome. Clin Infect Dis 18(suppl 1):S130-S133.
2. Ackermann M. 2006. Pathogenesis of gammaherpesvirus infections. Vet Microbiol 113:211-222.
3. Blaskovic D, Stancekova M, Svobodova J, Mistrikova J. 1980. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol 24:468.
4. Bortz E, Whitelegge JP, Jia Q, Zhou ZH, Stewart JP, Wu TT, Sun R. 2003. Identification of proteins associated with murine gammaherpesvirus 68 virions. J Virol 77:13425-13432.
5. Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R. 2003. NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77:8532-8540.
6. Callan MF. 2004. The immune response to Epstein-Barr virus. Microbes Infect 6:937-945.
7. + T cells. J Exp Med 184:863-871.
8. Chen G, Shankar P, Lange C, Valdez H, Skolnik PR, Wu L, Manjunath N, Lieberman J. 2001. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 98:156-164.
9. Cleare AJ. 2003. The neuroendocrinology of chronic fatigue syndrome. Endocrine Reviews 24:236-252.
10. Cohen JI. 2000. Epstein-Barr virus infection. N Engl J Med 343:481-492.
11. + T cells in vivo during latent murine gamma-herpesvirus infection. J Immunol 163:1481-1489.
12. D'Addario M, Ahmad A, Morgan A, Menezes J. 2000. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, P13-K and tyrosine kinases. J Mol Biol 298:765-778.
13. D'Addario M, Libermann TA, Xu J, Ahmad A, Menezes J. 2001. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways. J Mol Biol 308:501-514.
14. Damania B, Choi JK, Jung JU. 2000. Signaling activities of gammaherpesvirus membrane proteins. J Virol 74:1593-1601.
15. Dutia BM, Clarke CJ, Allen DJ, Nash AA. 1997. Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J Virol 71:4278-4283.
16. Dutia BM, Roy DJ, Ebrahimi B, Gangadharan B, Efstathiou S, Stewart JP, Nash AA. 2004. Identification of a region of the virus genome involved in murine gammaherpesvirus 68-induced splenic pathology. J Gen Virol 85:1393-1400.
17. Elsawa SF, Bost KL. 2004. Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis. J Immunol 172:516-524.
18. Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA. 2000. Latent murine gammaherpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 165:1074-1081.
19. Flano E, Jia Q, Moore J, Woodland DL, Sun R, Blackman MA. 2005. Early establishment of gamma-herpesvirus latency: implications for immune control. J Immunol 174:4972-4978.
20. Flano E, Kim I-J, Moore J, Woodland DL, Blackman MA. 2003. Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol 170:3828-3834.
21. Flano E, Woodland DL, Blackman MA. 2002. A mouse model for infectious mononucleosis. Immunologic Res 25:201-217.
22. Flano E, Woodland DL, Blackman MA, Doherty PC. 2001. Analysis of virus-specific CD4(+) T cells during long-term gammaherpesvirus infection. J Virol 75:7744-7748.
23. Gangappa S, Kapadia SB, Speck SH, Virgin HW. 2002. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol 76:11460-11468.
24. Guilleminault C, Mondini S. 1986. Mononucleosis and chronic daytime sleepiness: a longterm follow-up study. Arch Intern Med 146:1333-1335.
25. Haan KM, Aiyar A, Longnecker R. 2001. Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines. J Virol 75:3016-3020.
26. Hardy CL, Lu L, Nguyen P, Woodland DL, Williams RW, Blackman MA. 2001. Identification of quantitative trait loci controlling activation of TRBV4 CD8+ T cells during murine γ-herpes-induced infectious mononucleosis. Immunogenetics 53:395-400.
27. Hess RD. 2004. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol 42:3381-3387.
28. Iwatsuki K, Yamamoto T, Tsuji K, Suzuki D, Fujii K, Matsuura H, Oono T. 2004. A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infections. Acta Med Okayama 58:169-180.
29. Jabs WJ, Wagner HJ, Schlenke P, Kirchner H. 2000. The primary and memory immune response to Epstein-Barr virus infection in vitro is characterized by a divergent production of IL-1beta/IL-6 and IL-10. Scand J Immunol 52:304-308.
30. Josephs SF, Henry B, Balachandran N, Strayer D, Peterson D, Komaroff AL, Ablashi DV. 1991. HHV-6 reactivation in chronic fatigue syndrome. Lancet 337:1346-1347.
31. Jung S, Chung YK, Chang SH, Kim J, Kim HR, Jang HS, Lee JC, Chung GH, Jang YS. 2001. DNA-mediated immunization of glycoprotein 350 of Epstein-Barr virus induces the effective humoral and cellular immune responses against the antigen. Mol Cells 12:41-49.
32. Kapadia SB, Molina H, van B, V, Speck SH, Virgin HW. 1999. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol 73:7658-7670.
33. Kim I-J, Flano E, Woodland DL, Blackman MA. 2002. Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol 168:3958-3964.
34. Lagunoff M, Carroll PA. 2003. Inhibition of apoptosis by the gammaherpesviruses. Int Rev Immunol 22:373-399.
35. Larochelle B, Flamand L, Gourde P, Beauchamp D, Gosselein J. 1998. Epstein-Barr virus infects and induces apoptosis in human neutrophils. Blood 92:291-299.
36. Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG. 1997. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A 94:12616-12621.
37. Levitsky V, Masucci MG. 2002. Manipulation of immune responses by Epstein-Barr virus. Virus Res 88:71-86.
38. McColl SR, Roberge CJ, Larochelle B, Gosselin J. 1997. EBV induces the production and release of IL-8 and macrophage inflammatory protein-1 alpha in human neutrophils. J Immunol 159:6164-6168.
39. Moghaddam A, Rosenzweig M, Lee-Paritz D, Annis B, Johnson RP, Wang F. 1997. An animal model for acute and persistent Epstein-Barr virus infection. Science 276:2030-2033.
40. Moorman NJ, Willer DO, Speck SH. 2003. The gnmmaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol 77:10295-10303.
41. Moser JM, Upton JW, Gray KS, Speck SH. 2005. Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency. J Virol 79:5227-5231.
42. Nash AA, Sunil-Chandra NP. 1994. Interactions of the murine gammaherpesvirus with the immune system. Curr Opin Immunol 6:560-563.
43. Obar JJ, Donovan DC, Crist SG, Silvia O, Stewart JP, Usherwood EJ. 2004. T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics. J Virol 78:10829-10832.
44. Papanicolaou DA, Amsterdam JD, Levine S, McCann SM, Moore RC, Newbrand CH, Allen G, Nisenbaum R, Pfaff DW, Tsokos GC, Vgontzas AN, Kales A. 2004. Neuroendocrin aspects of chronic fatigue syndrome. Neuroimmunomodulation 11:66-74.
45. Peacock JW, Bost KL. 2001. Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis. Immunology 104:109-117.
46. Rajcani J, Blaskovic D, Svobodova J, Ciampor F, Huckova D, Stanekova D. 1985. Pathogenesis of acute and persistent murine herpesvirus infection in mice. Acta Virol 29:51-60.
47. Rickinson AB, Kieff E. 2001. Epstein-Barr virus. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, editors. Fields Virology. Philidelphia, PA: Lippincott Williams & Wilkins. p 2575-2627
48. Sarawar SR, Cardin RD, Brooks JW, Mehrpooya M, Hamilton-Easton AM, Mo XY, Doherty PC. 1997. Gamma interferon is not esential for recovery from acute infection with murine gammaherpesvirus 68. J Virol 71:3916-3921.
49. Sarawar SR, Cardin RD, Brooks JW, Mehrpooya M, Tripp RA, Doherty PC. 1996. Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol 70:3264-3268.
50. Simas JP, Efstathiou S. 1998. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 6:276-282.
51. Spath-Schwalbe E, Lange T, Perras B, Horst B, Fehm HL, Born J. 2000. Interferon-α acutely impairs sleep in healthy humans. Cytokine 12:518-521.
52. + T cells. J Gen Virol 80:477-483.
53. Stevenson PG, Efstathiou S. 2005. Immune mechanisms in murine gammaherpesvirus-68 infection. Viral Immunol 18:445-456.
54. Stewart JP, Janjua NJ, Pepper SD, Bennion G, Mackett M, Allen T, Nash AA, Arrand JR. 1996. Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol 70:3528-3535.
55. Stewart JP, Usherwood EJ, Ross A, Dyson M, Nash T. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 187:1941-1951.
56. Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol 73(Pt 9):2347-2356.
57. Sunil-Chandra NP, Efstathiou S, Fazakerley JK, Arno J, Nash AA. 1994. Virological and pathological features of mice infected with murine gammaherpesvirus 68. J Gen Virol 73:2347-2356.
58. Sunil-Chandra NP, Efstathiou S, Nash AA. 1992. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 73:3275-3279.
59. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. 2001. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K 18 that encodes a superantigen. Immunity 15:579-589.
60. Tanner J, Tosato G. 1991. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest 88:239-247.
61. Tanner J, Weis J, Fearon D, Whang Y, Kieff E. 1987. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50:203-213.
62. Tanner J, Whang Y, Sample J, Sears A, Kieff E. 1988. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J Virol 62:4452-4464.
63. Tibbetts SA, Loh J, van Berkel V, McClellan JS, Jacoby MA, Kapadia SB, Speck SH, Virgin HW. 2003. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. Journal of Virology 77:7696-7701.
64. Tibbetts SA, McClellan JS, Gangappa S, Speck SH, Virgin HW. 2003. Effective vaccination against long-term gammaherpesvirus latency. Journal of Virology 77:2522-2529.
65. Tobi M, Strauss SE. 1988. Chronic monomicleosis-a legitimate diagnosis. Postgrad Med 83:69-78.
66. Tripp RA, Hamilton-Easton AM, Cardin RD, Nguyen P, Behm FG, Woodland DL, Doherty PC, Blackman MA. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine γ-herpesvirus: role for a viral superantigen? J Exp Med 185:1641-1650.
67. Urquiza M, Lopez R, Patino H, Rosas JE, Patarroyo ME. 2005. Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells. J Biol Chem 280:35598-35605.
68. van Berkel V, Levine B, Kapadia SB, Goldman JE, Speck SH, Virgin HW. 2002. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J Clin Invest 109:905-914.
69. Virgin HW, Latrielle P, Wamsley R, Hallsworth K, Week KE, Del Canto AJ, Speck SH. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71:5894-5904.
70. Virgin HW, Speck SH. 1999. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr Opin Immunol 11:371-379.
71. Vollmer-Conna U, Fazou C, Cameon B, Li H, Brennan C, Luck L, Davenport T, Wakefield D, Hickie I, Lloyd A. 2004. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 34:1289-1297.
72. Wang GH, Garvey TL, Cohen JI. 1999. The murine gammaherpesvirus-68 M11 protein inhibits Fas- and TNF-induced apoptosis. J Gen Virol 80(Pt 10):2737-2740.
73. Week KE, Kim SS, Virgin HW, Speck SH. 1999. B cells regulate murine gammaherpesvirus 68 latency. J Virol 73:4651-4661.
74. Weinberg JB, Lutzke ML, Alfinito R, Rochford R. 2004. Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus. Viral Immunol 17:69-77.
75. White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, Clare AW. 1998. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatr 173:475-481.